(2-225) Review of the Investigational Use of Single, Dual, and Pan-Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Monday, December 9, 2024
10:45 AM – 11:45 AM
Location: Hall G, Lower Level
Category: Evaluative Study Topic: Investigational Drugs/Research
